Patients ‘at risk’ from sodium content in drugs

In a case control study tracking 1.2 million UK primary care patients for an average seven years, the team found those taking sodium-laced effervescent, dispersible and soluble medications had a 28% increased risk of all-cause mortality compared to patients taking non-sodium versions of the same drugs.

Sodium-containing medicines included soluble paracetamol, aspirin and calcium.

The cases had higher risks of non-fatal myocardial infarction and stroke, and a 70% increased risk of vascular death, driven largely by a sevenfold increased risk of